Allstate
ALL
$214.44
-3.40%
The Allstate Corporation is a leading US property and casualty insurer, with its core business focused on personal auto insurance, homeowners insurance, and other protection services sold primarily through a network of exclusive agents. The company is a dominant, established player in the highly competitive insurance industry, distinguished by its strong brand recognition and extensive distribution network. The current investor narrative centers on the company's recovery and margin trajectory following a challenging period of elevated claims severity, with recent financial results showing a significant rebound in profitability, which is driving a reassessment of its earnings power and capital return potential.…
ALL
Allstate
$214.44
Related headlines
ALL 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Allstate's 12-month outlook, with a consensus price target around $278.77 and implied upside of +30.0% versus the current price.
Average Target
$278.77
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$172 - $279
Analyst target range
Analyst coverage is limited, with only 4 analysts providing estimates, indicating this large-cap stock may have less concentrated institutional research focus than peers. The consensus sentiment, inferred from recent institutional ratings, appears mixed but leans cautiously positive, with firms like Mizuho, Keefe Bruyette & Woods, and JP Morgan maintaining 'Outperform' or 'Overweight' ratings, while Wells Fargo and Citigroup have 'Equal Weight' and 'Neutral' stances, respectively. A notable recent change was TD Cowen downgrading from 'Buy' to 'Hold' in January 2026, which may signal some near-term caution. The target price range implied by EPS estimates is wide, with a low EPS of $23.93 and a high of $26.87, translating to a price range of approximately $198 to $223 based on the forward PE, reflecting meaningful uncertainty about the earnings trajectory. The wide spread in estimates, coupled with the limited number of analysts, suggests lower consensus conviction and higher potential for price volatility based on quarterly earnings surprises relative to these benchmarks.
Bulls vs Bears: ALL Investment Factors
The bull case, centered on a dramatic profitability recovery and deep valuation discount, currently holds stronger evidence, supported by concrete data like a 23.1% net margin and a 5.29x trailing P/E. However, the bear case presents a credible counter-argument focused on the sustainability of these peak earnings. The single most important tension in the investment debate is whether Q4 2025's exceptional 23.1% net margin represents a new, sustainable level of earnings power for Allstate or a cyclical peak that will mean-revert. The resolution of this question, which will be determined by future underwriting results and claims trends, will dictate the stock's direction from its current technically overbought level.
Bullish
- Exceptional Profitability Recovery: Q4 2025 net income surged to $3.83 billion, yielding a net margin of 23.1%, a dramatic improvement from Q1 2025's 3.66% margin. This demonstrates successful underwriting actions and a significant rebound in earnings power, which is the core of the current investment thesis.
- Strong Balance Sheet & Capital Return: The company boasts a low debt-to-equity ratio of 0.245 and generated $9.88 billion in trailing twelve-month free cash flow. This robust financial position supports consistent dividends and substantial share buyback capacity, underpinning shareholder returns.
- Deeply Discounted Valuation: ALL trades at a trailing P/E of 5.29x and a forward P/E of 8.30x, which is exceptionally low for a profitable, large-cap financial. This valuation gap suggests the market is skeptical of earnings sustainability, creating a potential value opportunity if margins stabilize.
- High Return on Equity: The company's ROE stands at 33.59%, indicating highly efficient use of shareholder capital. This level of profitability, if maintained, significantly enhances the stock's intrinsic value and supports a higher valuation multiple over time.
Bearish
- Earnings Sustainability in Question: The wide gap between the trailing P/E (5.29x) and forward P/E (8.30x) implies analysts expect a significant earnings decline from Q4's peak. The cyclical nature of insurance profits raises valid concerns that the recent margin surge may not be fully sustainable.
- Limited Revenue Growth: Q4 2025 revenue grew only 1.52% year-over-year, and the business is mature with modest top-line expansion. The investment thesis is heavily reliant on margin expansion rather than revenue growth, which carries higher execution risk.
- Analyst Conviction is Low: Only 4 analysts cover the stock, and the implied target price range from EPS estimates is wide ($198-$223), reflecting high uncertainty. A recent downgrade from TD Cowen (Buy to Hold) signals near-term caution among some institutional followers.
- Vulnerable to Claims Severity Shocks: The company's core Property & Casualty business is exposed to catastrophic weather events and auto claims inflation. A return to the elevated severity seen in early 2025 could rapidly reverse the recent margin gains, as evidenced by the volatile quarterly income history.
ALL Technical Analysis
The stock is in a sustained uptrend, evidenced by a 1-year price change of +5.89% and a 3-month gain of +4.75%, currently trading at approximately 86% of its 52-week range ($188.08 to $222.23) near the $217.37 level. This positioning near the upper end of the range indicates strong momentum but also suggests the stock may be approaching a key technical resistance zone, which could lead to consolidation. Recent momentum shows a slight divergence, with a 1-month decline of -0.39% contrasting the positive longer-term trends, potentially signaling a short-term pause or profit-taking after the rally from the January lows near $192. The stock exhibits very low market correlation, with a beta of 0.207, meaning it is roughly 79% less volatile than the broader market (SPY), which is typical for a large-cap insurer but implies muted sensitivity to broad market swings. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $222.23 and support at the 52-week low of $188.08; a decisive breakout above resistance would confirm the bullish trend's continuation, while a breakdown below support would signal a more significant reversal, though the stock's low beta suggests such moves may be driven more by company-specific fundamentals than market sentiment.
Beta
0.21
0.21x market volatility
Max Drawdown
-11.5%
Largest decline past year
52-Week Range
$188-$228
Price range past year
Annual Return
+4.4%
Cumulative gain past year
| Period | ALL Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | +5.5% |
| 3m | +3.9% | +7.7% |
| 6m | +0.1% | +12.7% |
| 1y | +4.4% | +27.4% |
| ytd | +5.2% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALL Fundamental Analysis
Revenue growth is modest but stable, with Q4 2025 revenue of $16.59 billion representing a 1.52% year-over-year increase, though this follows a more volatile quarterly pattern where Q3 2025 revenue was higher at $17.06 billion. The Property Liability segment, generating $29.69 billion, is the overwhelming driver of the top line, while Protection Services contributes a smaller $1.83 billion. The growth trend suggests a mature business with pricing power, but the primary investment story is not top-line expansion. Profitability has dramatically improved, with Q4 2025 net income surging to $3.83 billion, yielding a robust net margin of 23.1%, and gross margin expanding to 52.96%. This marks a stark recovery from the weaker profitability seen in earlier 2025 quarters, such as Q1's net income of $595 million and net margin of 3.66%, indicating successful underwriting actions and favorable claims trends. The balance sheet is exceptionally strong, with a low debt-to-equity ratio of 0.245 and substantial free cash flow generation, evidenced by a trailing twelve-month FCF of $9.88 billion. The company's current ratio of 0.37 is low, which is typical for insurers whose current liabilities are dominated by reserves for future claims, but the high ROE of 33.59% and ample cash flow demonstrate efficient capital use and the capacity for shareholder returns through dividends and buybacks.
Quarterly Revenue
$16.6B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.52%
Latest Quarter
Free Cash Flow
$9.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALL Overvalued?
Given the company's substantial positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Allstate trades at a trailing PE of 5.29x and a forward PE of 8.30x based on estimated EPS. The significant gap between trailing and forward multiples suggests the market is pricing in expectations for normalized earnings that are lower than the exceptionally strong recent quarterly results, implying a reversion from peak profitability. Compared to sector averages, data is not available in the provided dataset for a direct industry PE comparison; however, the stock's low single-digit trailing PE appears deeply discounted relative to historical market norms for profitable financials, potentially reflecting skepticism about the sustainability of current margins or the cyclical nature of insurance earnings. Historically, the stock's own PE ratio has fluctuated widely, from deeply negative during loss periods to over 22x in early 2025; the current 5.29x trailing PE sits well below the 22.99x seen in Q1 2025, indicating the market is not extrapolating the recent earnings surge and may be valuing the stock at a point of cyclical caution, presenting a potential value opportunity if earnings stabilize at elevated levels.
PE
5.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -1458x~32x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is earnings volatility, not leverage or liquidity. Net income swung from $595 million in Q1 2025 to $3.83 billion in Q4 2025, demonstrating high sensitivity to claims cycles. While the debt-to-equity ratio is a low 0.245, the business model carries inherent underwriting risk concentrated in personal auto and homeowners insurance. Revenue growth is modest at 1.52% YoY, making the stock's valuation entirely dependent on maintaining elevated profitability, with any margin compression posing a direct threat to the earnings multiple.
Market & Competitive Risks: The key market risk is valuation compression. The stock's trailing P/E of 5.29x, while low, has historically been volatile, peaking above 22x in early 2025. If the market concludes recent earnings are not sustainable, a re-rating to a higher forward P/E (like the current 8.30x) on lower earnings could pressure the stock price. Competitive pressures in the P&C insurance sector are intense, and Allstate's low beta of 0.207 means it will not benefit from broad market rallies, leading to persistent underperformance versus indices like the SPY, as seen in its -19.3% 1-year relative strength.
Worst-Case Scenario: The worst-case scenario involves a rapid reversal of favorable claims trends, potentially due to a severe catastrophe season or a resurgence in auto repair and medical cost inflation. This would trigger a swift decline in underwriting margins back towards Q1 2025 levels, leading to significant earnings misses and analyst downgrades. The stock could realistically retreat to its 52-week low of $188.08, representing a downside of approximately -13.5% from the current price of $217.37. A drawdown to this level is plausible, given the stock's 11.48% max drawdown in the recent data period.